ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SXTP 60 Degrees Pharmaceuticals Inc

0.2351
0.0336 (16.67%)
Last Updated: 04:03:40
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
60 Degrees Pharmaceuticals Inc SXTP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0336 16.67% 0.2351 04:03:40
Open Price Low Price High Price Close Price Previous Close
0.2075 0.202 0.2352 0.2015
more quote information »

Recent News

Date Time Source Heading
08/5/202421:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/5/202421:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/4/202422:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/3/202422:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
21/2/202408:00EDGAR2Form 8-K - Current report
20/2/202423:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/2/202423:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
03/2/202407:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202404:00PRNUSWallachBeth Capital Announce Closing of 60 Degrees..
01/2/202403:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
31/1/202401:45PRNUSWallachBeth Capital Announces Pricing of 60 Degrees..
31/1/202401:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
30/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
23/1/202409:01EDGAR2Form 8-K - Current report
22/1/202423:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
17/1/202406:56EDGAR2Form 8-K - Current report
16/1/202423:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
26/12/202323:59GLOBE60 Degrees Pharma Announces IRB Approval of Phase IIA Study..
15/11/202323:29GLOBE60 Degrees Pharma Announces Type C Meeting with FDA to..
19/10/202323:31GLOBE60 Degrees Pharma to Present Review of Safety, Efficacy Data..
13/10/202307:16GLOBE60 Degrees Pharmaceuticals Suspends Phase IIB Study of..
19/9/202306:16GLOBE60 Degrees Pharma Withdraws COVID Phase IIB IND, Will..
06/9/202321:31GLOBE60 Degrees Pharmaceuticals to Participate in H.C. Wainwright..
30/8/202321:32GLOBE60 Degrees Pharmaceuticals Study Results Published by New..
22/8/202321:31GLOBE60 Degrees Pharmaceuticals Receives Additional U.S. Patent..
15/8/202321:31GLOBE60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB..
31/7/202321:59GLOBE60 Degrees Pharmaceuticals Awarded Canadian Patent Covering..
15/7/202303:30PRNUSWallachBeth Capital Announce Closing Of 60 Degrees..
15/7/202302:39GLOBE60 Degrees Pharmaceuticals Announces Closing of Initial..
13/7/202303:45PRNUSWallachBeth Capital Announce Pricing Of 60 Degrees..
13/7/202302:29GLOBE60 Degrees Pharmaceuticals Announces Pricing of Initial..

Your Recent History

Delayed Upgrade Clock